As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

COVID-19 Antibodies in Individuals Who Have Recovered from COVID-19 Infection

Clinical Trial Title: 
Evaluation of COVID-19 antibody titers in plasma of individuals who have recovered from COVID-19 infection.
Clinical Trial Protocol ID: 
20040507
Clinical Trial Investigator Name: 
James Moy, MD
Clinical Trial Protocol Description: 

Participates will donate a small blood sample. Plasma will be isolated from the blood samples. The plasma samples will be assayed for IgG, IgA and IgM antibody levels to COVID-19. In addition, the plasma samples will be assayed to determine if the antibodies are neutralizing antibodies (This will be performed in the future when the neutralizing tests are available). The neutralizing assays need to be performed in order to determine if the antibodies are likely to protect against future infections with COVID-19. The neutralizing assays will be performed in vitro to determine if the antibodies will inhibit infection of cell cultures by the COVID-19 virus.

In addition, participates will be tested for IgG and IgM antibodies with a finger stick test (a point of care test) that will let the participants know their results at that instant.

Clinical Trial Eligibility Criteria: 

To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
COVID-19
Contact Email: 
Contact Phone: 
(312) 942-6176
Contact Name: 
James Moy, MD